Company Profile
Medeon Biodesign provides the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system.
Its portfolio also includes Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia, Duett, a vascular graft system, PUMA, solution to treat orthopedic extremity injuries, ClickClean, a solution to view throughout laparoscopic surgeries, and AbClose to prevent port site herniation caused by improper closure.
It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.